November 2015

November 2015

November 2015 Issue


  • A new view for an old disease

    By David Huang, MD, PhD, et al.*

    SSADA software, coupled with OCT angiography shows potential in diagnosing, monitoring glaucoma.

  • A novel way to use an old technology

    By Vanessa Caceres, Contributing Editor

    Clinicians, researchers look at early clinical implications of DME using fundus autofluorescence.

  • A system born out of need, demand

    By Zack Tertel, Senior Editor

    Femtosecond laser cataract surgery suites help guide surgeons to accurate results.

  • Care shouldn’t end with vision loss

    By Karen Auge, Contributing Editor

    Your number of low-vision patients is likely to increase in coming years; be prepared.

  • How to choose the right anti-VEGF

    By Sanket U. Shah, MD, and Raj K. Maturi, MD

    With three to choose from, it’s important to know the seminal studies and what works for DME patients.

  • Telehealth reaches the unreachable

    By Karen Blum, Contributing Editor

    Internists, ophthalmologists team up remotely to screen diabetics, and find those with sight-threatening disease.

  • The current-care toolbox for DME

    By Michael P. Hood, MD and Jorge I. Calzada, MD

    Know your technologies, especially OCT. As for drug therapies, you’ll need to be intimate with the Big Three.

  • Trends in early diabetes diagnosis

    By Elizabeth R. Gaillard, PhD & Devi Kalyan Karumanchi, PhD

    Recent research could help clinicians get a handle on complications sooner.

  • When selling, plan and be patient

    By Robert Calandra, Contributing Editor

    Before you develop an exit strategy when selling your practice, know what to expect.